Skip to main content

Featured

Best Low-Cost ETFs for Canadian Investors in 2026 — Complete Guide

  Published: April 2026 | Reading time: 12 min | Category: Investing, Personal Finance, RRSP, TFSA If you want to build long-term wealth in Canada without paying a financial advisor 1–2% of your portfolio every year, low-cost ETFs are the answer. A single well-chosen ETF can give you instant exposure to hundreds or thousands of companies worldwide — for as little as 0.20% in annual fees. This guide covers the best ETFs available to Canadian investors in 2026 — for your TFSA, RRSP, and non-registered accounts — with clear explanations of what each one holds, what it costs, and who it's best for. Why Low-Cost ETFs Beat Most Other Investments for Canadians Before getting into specific funds, here's why this matters so much. The fee problem with mutual funds The average Canadian mutual fund charges a Management Expense Ratio (MER) of 2–2.5% per year. That might sound small, but on a $200,000 portfolio it's $4,000–$5,000 leaving your account every single year — regar...

article

Provincial Directive Curbs AHS Authority Over Private Surgical Contract Negotiations

 


In a significant policy shift, Alberta Health Minister Adriana LaGrange has stripped Alberta Health Services (AHS) of its authority to negotiate contracts with private surgical facilities. According to a government directive obtained by media, the change came after internal concerns—raised by the agency’s then-chief executive—over rising contract costs.

Documents, including a letter from former AHS CEO Athana Mentzelopoulos’s lawyer, allege that senior government officials—even involving Premier Danielle Smith’s former chief of staff—intervened in AHS’s procurement process to favor private companies. This interference reportedly undermined AHS’s established negotiation powers and raised serious questions about transparency in the province’s health system. 

A separate report in a Morning Update from Unpublished Newswire reiterated the move, noting that the directive is part of broader reforms aimed at reducing costs by leveraging competitive pricing in surgical services.  Meanwhile, a CityNews investigation has added context to the controversy, citing denials by private surgical providers who label the allegations of sweetheart deals as “false and baseless.” 

Critics and opposition leaders are calling for further inquiry into the decision-making process behind these changes, arguing that the shift could signal a move toward greater privatization of public health services. In contrast, government representatives insist that the directive is intended solely to improve efficiency and ensure more competitive pricing for publicly funded operations.

Comments